Study of a new medicine in healthy volunteers
Part of Infections, Lungs & breathing clinical trials.
This study tests a new drug, RLX-2508-102, in healthy people to see how safe it is and how the body handles it. It's an early step to learn if the medicine could be used for future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult (including people of Japanese background).
- You can give informed consent and follow the study rules.
- Your body weight is at least 45 kg (99 lbs) for women, 50 kg (110 lbs) for men, with a BMI between 19 and 32 (or 18-28 if you are Japanese).
- If you can have children, you must agree to use a highly effective birth control method.
- You have no significant health issues, allergies to the study drug, or recent participation in other trials.
- You have not smoked excessively in the past month and have no history of drug abuse in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medicine called TRX-100 to see if it can safely treat the flu. Healthy volunteers will be given the flu virus in a controlled setting, then the medicine, to see how well it works.
This study tests a new type of flu prevention medicine (called a monoclonal antibody) given as an injection. It is for people at higher risk of getting the flu, including those with certain health conditions or weakened immune systems.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This trial tests a new drug called QLS2312, given as an injection, to see if it is safe and how the body handles it. It is an early study in healthy volunteers that helps decide if the drug can be studied in people with certain conditions.
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.